Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

LYMPRO - it's all here:

http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/commercialization-track-2014-updating-lympro-test-progress/#sthash.MwT5GYMS.dpuf

"We are in a position to initiate a partnering process for the CLIA commercial launch of LymPro in the 2nd half of 2014."

"The Company remains on track to complete CLIA-grade validation and preparation of the Analytical Performance Package (APP) for LymPro in the 1st half of 2014."

"We have begun the implementation of our commercial scientific marketing strategy and that foundation begins with an analytically validated assay."

"We have recently hired Paul Jorgensen, our new Head of Product Development, to ensure the validation process is executed to the utmost commercial standards."

"We are currently seeking counsel with our regulatory consultants regarding the appropriate FDA strategy, and expect to initiate a dialogue with the agency upon completion of the APP for LymPro."

"We have retained Boston Healthcare to assist us with our reimbursement strategy and believe we have developed a strong framework that will form the basis of a successful and sustainable reimbursement profile for LymPro."

"We have put ourselves in a position to develop a meaningful commercialization and marketing partnership for our CLIA assay as we head into the 2nd quarter of 2014."

"We will continue to update our shareholders of critical milestones as they are achieved, with the next milestones expected in the 2nd quarter as we prepare the marketing process for LymPro’s commercialization in the US. This effort will begin with the investment community at the Cavendish Global Health Impact Forum at the United Nations in New York in early May and will continue with the scientific community at the Alzheimer’s Association’s International Conference (AAIC) in Copenhagen in mid-July. We believe these two conferences will set the stage for successful marketing efforts upon commercialization in the 2nd half of the year."